T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
E.W. Scripps
SSP
$310M
| $200K | ﹤0.01% |
81,078
-21,867
| -21% | -$67.3K |
|
2777
Compass Therapeutics
CMPX
$407M
| $199K | ﹤0.01% |
56,588
+9,646
| +21% | +$30.5K |
|
2778
The Joint Corp
JYNT
$119M
| $198K | ﹤0.01% |
20,704
+1,321
| +7% | +$14.3K |
|
2779
Butterfly Network
BFLY
$2.36B
| $197K | ﹤0.01% |
101,949
-39,518
| -28% | -$67.1K |
|
2780
NewtekOne
NEWT
$378M
| $197K | ﹤0.01% |
17,106
+1,817
| +12% | +$21.5K |
|
2781
ATN International
ATNI
$491M
| $195K | ﹤0.01% |
12,964
+648
| +5% | +$10.7K |
|
|
TTAM
2782
Titan America SA
TTAM
$2.9B
| $194K | ﹤0.01% |
12,947
+766
| +6% | +$11.3K |
|
2783
Pulse Biosciences
PLSE
$3.2B
| $193K | ﹤0.01% |
10,901
+503
| +5% | +$7.96K |
|
2784
Bridgewater Bancshares
BWB
$620M
| $192K | ﹤0.01% |
10,884
+271
| +3% | +$4.43K |
|
2785
Portillo's
PTLO
$365M
| $192K | ﹤0.01% |
29,656
+1,440
| +5% | +$12.2K |
|
2786
Luxfer Holdings
LXFR
$457M
| $190K | ﹤0.01% |
13,653
+709
| +5% | +$9.11K |
|
2787
Mama's Creations
MAMA
$790M
| $190K | ﹤0.01% |
18,046
+1,801
| +11% | +$16.3K |
|
|
FFWM
2788
DELISTED
First Foundation Inc
FFWM
| $189K | ﹤0.01% |
33,785
+3,951
| +13% | +$21.8K |
|
2789
MeiraGTx Holdings
MGTX
$1.17B
| $188K | ﹤0.01% |
22,776
| – | – |
|
2790
Midland States Bancorp
MSBI
$698M
| $188K | ﹤0.01% |
+10,931
| New | +$197K |
|
2791
First Bank
FRBA
$471M
| $187K | ﹤0.01% |
11,419
+836
| +8% | +$13.4K |
|
2792
Pacific Biosciences
PACB
$357M
| $187K | ﹤0.01% |
145,864
-133,373
| -48% | -$181K |
|
2793
ARKO Corp
ARKO
$505M
| $186K | ﹤0.01% |
40,695
+3,371
| +9% | +$15.9K |
|
2794
eHealth
EHTH
$38.8M
| $186K | ﹤0.01% |
42,936
| – | – |
|
2795
Spok Holdings
SPOK
$230M
| $186K | ﹤0.01% |
10,744
+542
| +5% | +$9.65K |
|
|
NEXN
2796
Nexxen International
NEXN
$598M
| $185K | ﹤0.01% |
19,939
+1,009
| +5% | +$10K |
|
2797
Designer Brands
DBI
$312M
| $184K | ﹤0.01% |
51,899
+17,313
| +50% | +$59.7K |
|
2798
The Honest Company
HNST
$540M
| $183K | ﹤0.01% |
49,636
+2,909
| +6% | +$12.3K |
|
2799
Latham Group
SWIM
$889M
| $183K | ﹤0.01% |
23,957
+1,431
| +6% | +$10.5K |
|
2800
Canterbury Park Holding Corp
CPHC
$81.4M
| $182K | ﹤0.01% |
11,247
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.